Skip to main content
SpringerLink
Log in

Risk of blood clots, death with high-dose tofacitinib

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. TGA = Therapeutic Goods Administration

  2. see Reactions 1742 p6; 803377653

Reference

  • Therapeutic Goods Administration. Tofacitinib: update - warning about increased risks of blood clots and of death at higher dose for certain patients. Internet Document : 15 Oct 2019. Available from: URL: https://www.tga.gov.au/alert/tofacitinib

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of blood clots, death with high-dose tofacitinib. Reactions Weekly 1776, 3 (2019). https://doi.org/10.1007/s40278-019-70161-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-70161-4

Search

Navigation